Showing results (851-860 of 1,615) with videos related to
Sort By:
Pageof 162
Cancer Journal (Sudbury, Mass.)|October 15, 2009
Progression-free survival: gaining on overall survival as a gold standard and accelerating drug developmentDavid Lebwohl, Andrea Kay, William Berg, et al.Cancer Journal (Sudbury, Mass.)|October 15, 2009
Overall survival: still the gold standard: why overall survival remains the definitive end point in cancer clinical trialsJames J Driscoll, Oliver RixeCancer Journal (Sudbury, Mass.)|October 15, 2009
Other paradigms: health-related quality of life as a measure in cancer treatment: its importance and relevancePeter C Trask, Ming-Ann Hsu, Richard McQuellonCancer Journal (Sudbury, Mass.)|March 22, 2021
Chimeric Antigen Receptor T-Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: Current Landscape in 2021Jordan Gauthier, Cameron J TurtleCancer Journal (Sudbury, Mass.)|March 22, 2021
How Do We Meet the Challenge of Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors?Adam J Schoenfeld, Roisin E O'CearbhaillCancer Journal (Sudbury, Mass.)|July 30, 2011
The role of informatics in promoting patient-centered careClaire F Snyder, Albert W Wu, Robert S Miller, et al.Cancer Journal (Sudbury, Mass.)|July 30, 2011
Data liquidity in health information systemsPaul K CourtneyCancer Journal (Sudbury, Mass.)|July 30, 2011
Toward an integrated knowledge environment to support modern oncologyPatrick M Blake, David A Decker, Timothy M Glennon, et al.Cancer Journal (Sudbury, Mass.)|September 29, 2011
Combined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck: a phase II trial of the Sarah Cannon oncology research consortiumJohn D Hainsworth, David R Spigel, F Anthony Greco, et al.Pageof 162